CJC-1295 No DAC 5 mg

Research Peptide for Growth Hormone Support and Recovery Studies

CJC-1295 No DAC 5 mg is a research-grade peptide studied for its role in stimulating natural growth hormone (GH) release. It functions as a growth hormone–releasing hormone (GHRH) analog, allowing researchers to examine GH pulse activity, tissue repair, and metabolic regulation.
Because it lacks the DAC (Drug Affinity Complex) component, CJC-1295 No DAC 5 mg provides a shorter, more controllable duration of action—making it ideal for experiments that require precise GH-release timing.

What Makes CJC-1295 No DAC Unique

CJC-1295 No DAC binds to pituitary GHRH receptors to trigger short-term GH secretion and a secondary rise in IGF-1.
This shorter half-life distinguishes it from the long-acting DAC form, enabling researchers to study natural pulsatile GH patterns instead of sustained elevation.
The result is a clear model for evaluating recovery cycles, metabolic adaptation, and endocrine regulation under laboratory conditions.

Key Research Applications

Scientists use CJC-1295 No DAC 5 mg in preclinical models exploring:

• Growth Hormone Pulsatility – mapping GH frequency and amplitude.
• Muscle Recovery and Repair – studying GH-driven protein synthesis.
• Collagen and Skin Elasticity – assessing dermal regeneration pathways.
• Metabolic and Fat-Utilization Mechanisms – examining GH-related lipolysis and energy balance.
• Sleep and Circadian Cycles – evaluating GH release during rest periods.

Because it produces transient GH peaks, CJC-1295 No DAC 5 mg is often combined in research protocols with other growth-hormone secretagogues for synergistic evaluation.

Mechanism of Action

CJC-1295 No DAC 5 mg acts as a synthetic GHRH analog that interacts with the anterior pituitary to stimulate endogenous GH.
Research indicates it may:

• Amplify short-term GH and IGF-1 pulses.
• Promote cellular repair and protein turnover.
• Enhance fat metabolism through GH-mediated pathways.
• Support collagen production and tissue elasticity.

Its rapid onset and limited duration make it valuable for observing feedback control within GH release cycles.

Why Researchers Choose GRAM Peptides

GRAM Peptides ensures scientific precision, transparency, and reproducibility across every batch:

• Pharmacist-Formulated – developed by a licensed compounding pharmacist with 20 + years of experience.
• Made in the USA – produced under ISO-compliant clean-room conditions.
• Third-Party Tested – purity, potency, and identity verified by independent labs.
• Transparent Labeling – each vial includes verified lot data and COA confirmation.

Researchers rely on CJC-1295 No DAC 5 mg from GRAM Peptides for consistent, high-quality materials designed for controlled laboratory evaluation.

Common Research Areas

• Endocrine and GH Regulation Studies
• Muscle and Tissue Recovery Models
• GH/IGF-1 Metabolic Research
• Cellular Repair and Anti-Aging Mechanisms

For reference material, visit the National Library of Medicine (PubMed) to explore peer-reviewed studies on GHRH analogs and growth hormone modulation.

Combine with Ipamorelin for Comprehensive GH Research

Many researchers pair CJC-1295 No DAC 5 mg with Ipamorelin 5 mg to study dual-pathway GH stimulation—mimicking natural synergy between GHRH and GHRP signals.
This combination allows investigation of both pituitary and hypothalamic contributions to GH release and recovery.

Frequently Asked Questions

What is CJC-1295 No DAC 5 mg?
A research peptide that mimics natural GHRH to study GH release and tissue recovery.

How does CJC-1295 No DAC differ from the DAC form?
The DAC variant extends half-life for long-term studies, while the No DAC form allows short-term, high-control GH experiments.

Is CJC-1295 No DAC FDA-approved?
No. It is for Research Use Only (RUO) and not approved for human or veterinary therapeutic use.

How is the peptide supplied?
Each vial contains 5 mg of lyophilized CJC-1295 No DAC powder for reconstitution under sterile laboratory conditions.

Related Peptides

• CJC-1295 with DAC 5 mg – extended-release form for long-duration models.
• Tesamorelin 10 mg – examined for IGF-1 modulation and metabolic effects.
• Ipamorelin 5 mg – studied for complementary GH release pathways.

Disclaimer

CJC-1295 No DAC 5 mg is sold for Research Use Only (RUO). Not for human consumption, medical, or diagnostic applications.